Systems and methods for compounding a preparation using a premix solution

US9475019B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9475019-B2
Application numberUS-201414774502-A
CountryUS
Kind codeB2
Filing dateMar 14, 2014
Priority dateMar 15, 2013
Publication dateOct 25, 2016
Grant dateOct 25, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Computer systems and non-transitory computer readable media for determining an amount of an ingredient for a preparation for a requested therapy (e.g., an order or a prescription) includes an identifier, volume, and amounts of first and second compounds in each of a plurality of premix solutions. A predefined formulary comprising a formulary concentration of each of a plurality of additions is provided. A premix solution is selected. An amount of a first additions to be added to the premix solution may be selected. A number of bags of the premix solution, needed to satisfy a volume associated with the selected premix solution, are optionally reserved. An additive volume is determined at least by the specified first amounts of the first addition and a corresponding formulary concentration.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for use of an automatic compounder for compounding a preparation corresponding to a requested therapy to be administered to a patient, the method comprising: receiving, at the compounder, a manifest corresponding to the preparation to be compounded, wherein the manifest comprises an indication of a receiving receptacle that contains a volume of at least a first component for inclusion in the preparation, and wherein the manifest comprises an indication of an amount of at least one additive to be added to the receiving receptacle; establishing fluid interconnection between a delivery port of the compounder and the receiving receptacle and between an input port of the compounder and an additive receptacle containing the additive to be added to the receiving receptacle, wherein the receiving receptacle comprises a prepackaged container containing the volume of at least the first component; and delivering, using a preprogrammed logic of the compounder, the amount of the additive from the additive receptacle to the receiving receptacle at least partially based on the manifest, wherein the preprogrammed logic of the compounder automatically controls flow from the input port to the delivery port; wherein the receiving receptacle comprises an administration receptacle from which the preparation is to be administered to the patient. 2. The method of claim 1 , wherein the manifest comprises an indication of an amount for each of a plurality of additives to be added to the receiving receptacle. 3. The method of claim 2 , wherein the establishing further comprises establishing fluid interconnection between a plurality of additive receptacles corresponding to the plurality of additives and a plurality of respective input ports of the compounder. 4. The method of claim 3 , wherein the delivering further comprises selectively controlling flow from each of said plurality of input ports and the delivery port to deliver the amount of each of the plurality of additives at least partially based on the manifest. 5. The method of claim 4 , further comprising: maintaining the fluid interconnection between the delivery port of the compounder and the receiving receptacle during the delivering of the amount of each of the plurality of additives. 6. The method of claim 5 , wherein the establishing comprises a first fluid interconnection between the delivery port of the compounder and the receiving receptacle. 7. The method of claim 6 , wherein the receiving receptacle comprises a premix solution comprising a parenteral nutrition (PN) solution. 8. The method of claim 2 , further comprising sequencing, using the preprogrammed logic, the delivery of the plurality of additives to reduce interaction of potentially incompatible ingredients. 9. The method of claim 1 , wherein the delivering is performed in an at least partially automated fashion by the compounder. 10. The method of claim 1 further comprising: receiving the receiving receptacle at a receptacle support of the compounder. 11. The method of claim 10 , further comprising: measuring, at the compounder in response to receiving the receiving receptacle, at least one beginning physical property of the receiving receptacle prior to the delivering; and comparing, using the preprogrammed logic, the least one beginning physical property of the receiving receptacle measured by the compounder to an expected physical property for the receiving receptacle. 12. The method of claim 11 , further comprising: analyzing, after the delivering using the preprogrammed logic, at least one ending physical property of the receiving receptacle that is determined at the compounder to an expected ending physical property, wherein the expected ending physical property is at least partially based on the beginning physical property and the plurality of amounts of additives. 13. The method of claim 10 , further comprising: obtaining, at the compounder, information indicative of the identity of the received receiving receptacle prior to the establishing. 14. The method of claim 13 , wherein the obtaining includes reading, with the compounder, a machine readable indicia corresponding to the receiving receptacle. 15. The method of claim 13 , wherein the machine readable indicia comprises one of an RFID tag or a bar code physically provided with the receiving receptacle. 16. The method of claim 15 , wherein the machine readable indicia corresponding to the received receiving receptacle is compared, using the preprogrammed logic, to the indication of the receiving receptacle from the manifest to verify a received receiving receptacle corresponds to the indication of the receiving receptacle. 17. The method of claim 10 further comprising: prompting a user to locate the receiving receptacle at the receptacle support and establish fluid interconnection between the receiving receptacle and the delivery port. 18. The method of claim 1 , wherein the receiving of the manifest comprises accepting inputs from a user by way of manual user inputs at a user interface at the compounder. 19. The method of claim 1 , wherein the receiving of the manifest comprises obtaining a manifest output corresponding to the preparation as machine readable data. 20. The method of claim 19 , wherein the manifest output is automatically generated based on a first selection corresponding to a premix solution and a second selection corresponding to the additive. 21. The method of claim 1 , wherein the delivery comprises adding from about 0.1 ml of the additive to the receiving receptacle to about 750 ml of the additive to the receiving receptacle. 22. The method of claim 1 , wherein the receiving step further comprises: generating the manifest. 23. A method for use of an automatic compounder for compounding a preparation corresponding to a requested therapy to be administered to a patient, the method comprising: receiving, at the compounder, a manifest corresponding to the preparation to be compounded, wherein the manifest comprises an indication of a receiving receptacle that contains a volume of at least a first component for inclusion in the preparation, and wherein the manifest comprises an indication of an amount of at least one additive to be added to the receiving receptacle; establishing fluid interconnection between a delivery port of the compounder and the receiving receptacle and between an input port of the compounder and an additive receptacle containing the additive to be added to the receiving receptacle, wherein the receiving receptacle comprises a prepackaged container containing the volume of at least the first component; delivering, using a preprogrammed logic of the compounder, the amount of the additive from the additive receptacle to the receiving receptacle at least partially based on the manifest, wherein the preprogrammed logic of the compounder automatically controls flow from the input port to the delivery port; and generating the manifest, wherein the generating comprises: receiving a first selection of a premix solution from a plurality of premix solutions and an ordered amount of the premix solution, wherein the first selection of the premix solution corresponds to the receiving receptacle, and wherein each respective one of the premix solutions includes a predetermined description at least comprising: (i) an identifier for the respective premix solution, (ii) a volume of the respective premix solution in a prepackag

Assignees

Inventors

Classifications

  • with discontinuous action · CPC title

  • Operations & Transport · mapped topic

  • A61J3/002Primary

    Compounding apparatus specially for enteral or parenteral nutritive solutions (bottling liquids B67C) · CPC title

  • Operations & Transport · mapped topic

  • Operations & Transport · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9475019B2 cover?
Computer systems and non-transitory computer readable media for determining an amount of an ingredient for a preparation for a requested therapy (e.g., an order or a prescription) includes an identifier, volume, and amounts of first and second compounds in each of a plurality of premix solutions. A predefined formulary comprising a formulary concentration of each of a plurality of additions is …
Who is the assignee on this patent?
Baxter Corp Englewood
What technology area does this patent fall under?
Primary CPC classification A61J3/002. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).